12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
The article highlights the pre-market movements of several healthcare stocks. TFF Pharmaceuticals, Centene, and Nexalin Technology are among the gainers, while Monopar Therapeutics and Quince Therapeutics are notable losers.
October 25, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Centene's stock rose 12.62% following the release of its Q3 earnings report.
The rise in stock price is directly linked to the Q3 earnings report, indicating positive results or outlook.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Nexalin Technology shares increased by 9.31% in pre-market trading.
The pre-market rise suggests positive investor sentiment, potentially due to news or market conditions.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
TFF Pharmaceuticals saw a significant pre-market increase of 27.9%, indicating strong investor interest.
The substantial pre-market gain suggests positive sentiment or news, likely leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Monopar Therapeutics experienced a significant drop of 23.9% in pre-market trading.
The sharp decline indicates negative sentiment or news, likely leading to a short-term price decrease.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Quince Therapeutics' stock declined by 15.97% in pre-market trading.
The decline suggests negative investor sentiment, possibly due to unfavorable news or market conditions.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 85